Immunologic Deficiency Syndromes Clinical Trial
Official title:
Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans, a Pilot Study
The purpose of this study is to test wether orally administered Beta-glucan has systemic effects in humans.
The immunostimulatory properties of mushrooms have been recognized for centuries, and "medicinal" mushrooms are still widely used in alternative medicine all over the world. Although a number of fungal components have been implicated in these properties, Beta-glucans have attracted the most attention. However, although Beta-glucans are widely used as a health food supplement, their immunomodulatory effects after administration in humans have not yet been determined. ;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04798677 -
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
|
N/A | |
| Completed |
NCT02783482 -
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
|
Phase 3 | |
| Completed |
NCT00598481 -
ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID
|
Phase 2 | |
| Completed |
NCT00468273 -
A Clinical Study of Intravenous Immunoglobulin
|
Phase 3 | |
| Enrolling by invitation |
NCT03478670 -
Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)
|
||
| Terminated |
NCT00006054 -
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
|
N/A | |
| Recruiting |
NCT03920735 -
Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients
|
||
| Completed |
NCT00001438 -
A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes
|
Phase 2 | |
| Terminated |
NCT00811174 -
Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases
|
Phase 3 | |
| Completed |
NCT00006131 -
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
|
N/A | |
| Recruiting |
NCT02735824 -
Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
|
||
| Completed |
NCT02554630 -
Novel Mechanisms and Approaches to Treat Neonatal Sepsis
|
||
| Recruiting |
NCT03835312 -
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
|
N/A | |
| Completed |
NCT00176865 -
Stem Cell Transplant for Immunologic or Histiocytic Disorders
|
Phase 2 | |
| Completed |
NCT00001646 -
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
|
Phase 3 | |
| Completed |
NCT02630082 -
Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
|
N/A | |
| Completed |
NCT00001158 -
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
|
N/A |